Combining the results of IHC and imaging technologies, it could be found that the CK19/GPC3 expression pattern, tumor number and size, as well as histological grading degrees could be retrieved, which indicated that the novel risk score model could be potentially used in the therapeutic decision making. The gene discussed is KRT19; the disease is neoplasm.